Does Medicare Cover GLP-1 Medications? (2026)
Coverage rules, copays, prior auth requirements, and appeal options for Medicare members seeking Wegovy, Ozempic, Zepbound, or Mounjaro.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Coverage by Medication[8]
| Medication | Medicare Coverage |
|---|---|
| Wegovy (semaglutide) | Medicare Part D excludes drugs prescribed for weight loss under the statutory exclusion at SSA 1860D-2(e)(2)(A). Per CMS HPMS memo issued March 20, 2024, Wegovy may be covered under Part D when prescribed for the FDA-approved cardiovascular-risk-reduction indication (reducing risk of MACE in adults with established CVD who are obese or overweight, supported by the SELECT trial). Plan-level coverage and PA criteria vary. |
| Ozempic (semaglutide) | Covered under Medicare Part D for type 2 diabetes diagnosis. |
| Zepbound (tirzepatide) | Not covered under Medicare Part D for weight loss (statutory exclusion). Zepbound has a separate FDA approval for moderate-to-severe obstructive sleep apnea in adults with obesity; Part D coverage for the OSA indication is plan-dependent. |
| Mounjaro (tirzepatide) | Covered under Medicare Part D for type 2 diabetes diagnosis. |
| Typical copay (when covered) | $30-$100 / month |
If You're Denied by Medicare
If Medicare denies coverage for Wegovy or Zepbound, you still have affordable options. Compounded semaglutide and tirzepatide are dispensed by licensed 503A pharmacies[7] and cost $149-$299/month — a fraction of brand-name pricing. Brand-name GLP-1 medications are generally an HSA/FSA-eligible medical expense with a prescription[5], and many plan administrators also accept compounded GLP-1s with a Letter of Medical Necessity. The providers below ship to all 50 states and offer same-week prescriptions.
Medicare statutory note: Medicare Part D is statutorily prohibited from covering “agents when used for anorexia, weight loss, or weight gain” under § 1860D-2(e)(2)(A) of the Social Security Act. This is why Wegovy and Zepbound are not covered for obesity indications, even when they are otherwise on a plan's formulary for diabetes or cardiovascular indications[3].
Before going cash-pay, file a formal appeal with Medicare. Many denials are overturned with a Letter of Medical Necessity from your prescriber documenting BMI, comorbidities, and prior failed weight-loss attempts.
Top cash-pay GLP-1 providers if Medicare won't cover it
Compounded semaglutide and tirzepatide are widely available on a cash-pay basis — often for less than a plan's copay after a denial. These are our top-ranked picks, followed by a fuller list of alternatives.
Top picks
Compare the top providers at a glance
Logos, our editorial rating, price, medications, and coverage — the fastest way to narrow the list.
- ★ Editor's Pick
mainstream telehealth GLP-1 access
From /mo$99Coverage50 statesMedicationsSemaglutideTirzepatide - Best Budget
best overall value
From /mo$99Flat at every doseCoverage50 statesMedicationsSemaglutideTirzepatide lab-monitored compounded GLP-1 with mandatory video visit
From /mo$112Flat at every doseCoverage39 statesMedicationsSemaglutideTirzepatide- Nationwide Coverage
compounded GLP-1/GIP combo on a yearly plan with free shipping
From /mo$149Flat at every doseCoverage50 statesMedicationsTirzepatideSemaglutide mainstream telehealth GLP-1 access
From /mo$99Flat at every doseCoverage50 statesMedicationsSemaglutideTirzepatide
| Provider | Rating | From /mo | Medications | Coverage | |
|---|---|---|---|---|---|
★ Editor's Pick mainstream telehealth GLP-1 access | $99 | SemaglutideTirzepatide | 50 states | Visit → | |
Best Budget best overall value | $99 Flat pricing | SemaglutideTirzepatide | 50 states | Visit → | |
 lab-monitored compounded GLP-1 with mandatory video visit | $112 Flat pricing | SemaglutideTirzepatide | 39 states | Visit → | |
Nationwide Coverage compounded GLP-1/GIP combo on a yearly plan with free shipping | $149 Flat pricing | TirzepatideSemaglutide | 50 states | Visit → | |
 mainstream telehealth GLP-1 access | $99 Flat pricing | SemaglutideTirzepatide | 50 states | Visit → |
More compounded alternatives
Editorial score · methodology
Aurelius Health Group
Best for: transparent, care-inclusive compounded tirzepatide microdosing
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Chronos Body Health & Wellness
Best for: physician-led GLP-1 care with brand-name and microdosing options
Editorial score · methodology
Get StartedRead full Chronos Body Health & Wellness review →Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Iron Med RX
Best for: oral or injectable compounded GLP-1, one provider, account-gated pricing
Editorial score · methodology
Kairos Aesthetic and Longevity Medicine
Best for: Irving/Dallas patients wanting in-person, physician-led weight loss care
Editorial score · methodology
Get StartedRead full Kairos Aesthetic and Longevity Medicine review →Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Sprout Health
Best for: LegitScript-verified compounded GLP-1 via named pharmacies
Editorial score · methodology
Vyvron
Best for: a locked founding rate from a platform that names its clinical partner and holds a real LegitScript seal
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Wegovy · Drugs and brands
- Zepbound · Drugs and brands
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Prior authorization (PA) · Insurance and regulatory
- Step therapy · Insurance and regulatory
- Off-label use · Insurance and regulatory
- Compounded GLP-1 · Pharmacy and drug forms
Medicare Coverage Updates
Get notified when Medicare GLP-1 coverage rules change.
Sources & methodology — as of August 2026
- 1.KFF — Employer Health Benefits Annual Survey— Kaiser Family Foundation.
- 2.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 3.CMS — Medicare Part D Prescription Drug Coverage Program— Centers for Medicare & Medicaid Services.
- 4.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
- 5.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.
- 6.U.S. Department of Labor — ERISA and Employer Health Plans— U.S. Department of Labor, Employee Benefits Security Administration.
- 7.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 8.Weight Loss Rankings insurer coverage index (manually curated formulary data)— Weight Loss Rankings.